Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mirabel Meds vs MyStart Health

Mirabel Meds
Graded #396

Lower grade

vs+9.599999999999994
MyStart Health
Graded #168

Higher grade

The verdict

MyStart Health takes it — 67.1/100 to 57.5/100.

MyStart Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MyStart Health offers all-inclusive compounded semaglutide and tirzepatide at $299/month with a price-lock guarantee, same-day physician consultations, and 24/7 care team access.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMyStart Health +3
45
48
Dose & formulationMyStart Health +43
40
83
Clinical oversightMyStart Health +5
79
84
Labs & monitoringMyStart Health +12
54
66
FulfillmentMirabel Meds +5
83
78
Contract termsMirabel Meds +24
55
31
Mirabel Meds · left barMyStart Health · right bar

The numbers

MetricMirabel MedsMyStart Health
WeighScore57.5/10067.1/100
GradeCC
Scorecard rank#396#168
SemaglutideNot disclosed$299/mo (all doses, compounded)
TirzepatideNot disclosed$299/mo (all doses, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Mirabel Meds

Graded #396 · C

Strengths

  • LegitScript certified with board-certified Internal Medicine physician oversight
  • Compounded semaglutide, tirzepatide, and GLP-1 microdose injection options
  • White-glove concierge — direct provider messaging, no automated bots
  • Cold-chain temperature-controlled delivery to all 50 states
  • Monthly clinical reviews and dose adjustments included with every plan

Where it loses points

  • Pricing not publicly disclosed — requires a consultation to receive a quote
  • Compounded medications are not FDA-approved individual drugs
  • No named pharmacy partner disclosed on public pages
  • Labs not mentioned on any public page — baseline bloodwork protocol unknown
  • Concierge positioning suggests premium pricing above market average
MyStart Health

Graded #168 · C

Strengths

  • Price Lock Guarantee — your $299 base rate doesn't rise as your dose escalates
  • Fast onboarding: roughly 5-minute intake, 24-hour prescription turnaround, 2–4 day shipping
  • 24/7 care team access with unlimited clinician messaging included
  • LegitScript certified
  • Clear Section 503A compounding disclosure on every landing page

Where it loses points

  • Not BBB accredited — C+ rating with 10 complaints, mostly shipping delays and support access
  • Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
  • Markets oral tirzepatide, but no FDA-approved oral tirzepatide exists
  • Very new company (incorporated May 2024) with a limited track record
  • Pharmacy partners not named, so 503A compliance can't be independently verified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard